Clinical Trials Logo

Deglutition Disorders clinical trials

View clinical trials related to Deglutition Disorders.

Filter by:

NCT ID: NCT03311425 Active, not recruiting - Dysphagia Clinical Trials

Effect of Local Intraoperative Steroid on Dysphagia After ACDF

Start date: August 1, 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if the incidence and duration of postoperative dysphagia are improved in the participants receiving a local injection of methylprednisolone with systemic dexamethasone when compared to those receiving the usual systemic dexamethasone.

NCT ID: NCT03306134 Recruiting - Swallowing Disorder Clinical Trials

The Effect of Beta-blockers in Substance P Levels and the Swallowing Function

BETASP
Start date: June 5, 2017
Phase: N/A
Study type: Observational

A non-randomised, prospective study to assess the effects of beta-blockers on substance P levels and the swallowing function. The study is going to be carry out in the Gastrointestinal Physiology Laboratory of the Hospital de Mataró (Spain). All participants will be actively recruited from a Linked hospital and primary care database. We include two groups: the first group (group 1) are participants taking beta-blockers and the second group (group 2) are participants not-taking beta-blockers.

NCT ID: NCT03284892 Not yet recruiting - Clinical trials for Endotracheal Intubation

Screening and Intervention of Postextubation Dysphagia

Start date: September 15, 2017
Phase: N/A
Study type: Interventional

This study is to develop and test the accuracy of a two-step post-extubation dysphagia screening and the effects of PED Care intervention on reducing time to resume oral intake, rates of penetration and intervention at 10 days postextubation, and incidences of 30-day aspiration pneumonia in adult patients with prolonged intubation (≥48 hours) under a randomized controlled trial (RCT) design.

NCT ID: NCT03284125 Not yet recruiting - Clinical trials for Peripheral Facial Paralysis

Lengthening Temporalis Myoplasty and Improvement of Primary Swallowing Disorders in Facial Paralysis

MATPF
Start date: September 2017
Phase: N/A
Study type: Observational

The facial paralysis is a frequent disease causing important functionals swallowing dysfunctions. The purpose of our study was to evaluate the improvement of the swallowing disorders after surgery by lengthening temporalis myoplasty (LTM) in the facial paralysis. This prospective study has realised on the following of patients affected by facial paralysis treated by LTM. Self-administered questionnaires and clinics tests had realized to analyze three components oh the oral phase of the swallowing ( drooling, mastication and handicap). The evaluations was realized before the surgery and at 3 and 6 months after .

NCT ID: NCT03274947 Not yet recruiting - Stroke Clinical Trials

The Utility of Cerebellar Transcranial Magnetic Stimulation in the Neurorehabilitation of Dysphagia After Stroke

Start date: July 2018
Phase: N/A
Study type: Interventional

The study is designed to explore the effectiveness of non-invasive cerebellar stimulation to enhance motor plasticity in the cortex after stroke. The investigators have shown that the human cerebellum is strongly activated during the act of swallowing and when stimulated with single TMS pulses can strongly facilitate the corticobulbar projection to the pharynx in humans. More recently the investigators have identified the most relevant frequency of stimulation of the cerebellum that can produce longer term excitation in the human swallowing motor system. The investigators therefore believe that the potential for cerebellar stimulation in improving swallowing is much greater than other methods for two reasons. Firstly, previous work has shown that unlike successful recovery of hand/arm function which relies on restoring activity in the stroke hemisphere, recovery of swallowing function relies on increased excitability in intact projections from the non-stroke hemisphere. The investigators believe that methods that can enhance these undamaged pathways have a greater chance of inducing recovery in the human swallowing system in unilateral stroke. Additionally cerebellar stimulation produces very high levels of corticobulbar excitation it may also have the advantage of improving dysphagia in posterior fossa strokes. Second, the human cerebellum is relatively easy to target and stimulate and has reduced risk of inducing unwanted effects (such as seizures) which as a consequence makes cerebellar stimulation a more pragmatic method for delivering therapeutic neurorehabilitation to dysphagic stroke patients compared to other more complex/riskier methods. A final factor is that the investigators have developed a "virtual lesion" model of swallowing dysfunction in healthy volunteers which can be reversed quite successfully with other neuro-stimulation protocols. The investigators can therefore use this model to test the effectiveness of cerebellar stimulation protocols (ipsilateral and contralateral cerebellar sites) before choosing the most effective side to apply stimulation in a proof of principle trial/study in a small group of sub-acute dysphagic patients. The hypotheses are that cerebellar TMS will: i. Reverse the brain inhibition and behavioural dysfunction following a virtual lesion model of disrupted swallowing in healthy brain (phase 1); ii. Reduce the degree of aspiration in acute dysphagia after a stroke (phase 2).

NCT ID: NCT03256149 Recruiting - Dysphagia Clinical Trials

High Dose Steroids for Dysphagia

SHDD
Start date: March 24, 2015
Phase: N/A
Study type: Interventional

Few existing data currently indicates that anti-inflammatory drugs could help diminish the local cervical inflammation tough to cause the dysphagia, hoarseness and dyspnea after an anterior surgical approach to the spine. This study aims to evaluate the effect of high dose of steroids on dysphagia after an anterior cervical spine procedure. Patients subjected to a cervical spine surgery through an anterior approach will be randomized to a treatment group receiving 3 doses of IV dexamethasone (decadron) and a placebo group receiving saline. Outcome will be measured with dysphagia scales, modified barium swallow and rhino-pharyngo-laryngoscopy, all done pre and post-operatively. Secondary outcomes involve neurological condition, pain and fusion rate.

NCT ID: NCT03253354 Recruiting - Parkinson Disease Clinical Trials

Neurostimulation for Dysphagia in Parkinson's Disease

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

This study will explore the effects of 3 different neurostimulation methods on swallowing function in patients with dysphagia secondary to Parkinson's Disease

NCT ID: NCT03247374 Not yet recruiting - Clinical trials for Deglutition Disorders

Bio-feedback Treatment for Dysphagic Post-stroke Patients

BIO_DYS
Start date: August 28, 2017
Phase: N/A
Study type: Interventional

The primary purpose of the study is to evaluate whether the effect of bio-feedback dysphagia treatment is more effective than a control treatment in post-stroke patients. This study will be a randomized, single-blind controlled pilot study. The investigators intend to recruit 40 patients who have suffered a stroke and have dysphagia. Twenty patients will undergo training with bio-feedback (experimental group) and the other 20 patients will undergo standard training, using only verbal feedback rather than visual feedback (control group). The authors hypothesize that in the control group the efficacy of the treatment will be lower in the absence of immediate visual feedback of strength and coordination of the swallowing act.

NCT ID: NCT03244553 Enrolling by invitation - Dysphagia Clinical Trials

Treatment of Dysphagia and Ineffective Esophageal Motility With Prucalopride: A Pilot Study

IEMPru
Start date: August 2017
Phase: Phase 2
Study type: Interventional

This study will test prucalopride (a prokinetic drug currently approved by Health Canada for treatment of constipation) as a treatment for Ineffective Esophageal Motility (IEM). Adult patients with previously diagnosed IEM will be invited to participate by the investigators. The participants will take the study medication for 5 days and on the final day of medication undergo an esophageal manometry procedure at the Calgary Gut Motility Centre to measure esophageal function. Symptoms and side effects will be tracked at baseline and on Day 5.

NCT ID: NCT03241615 Completed - Clinical trials for Neurogenic Dysphagia

Dysphagia Symptom Severity and Quality of Life

Start date: August 8, 2017
Phase: N/A
Study type: Observational

The aim of the study is to investigate the relationship between dysphagia symptom severity and quality of life of the patients with neurogenic dysphagia.